Kathleen J. Propert - Publications

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Area:
Biostatistics Biology

116 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Fett N, Haynes K, Propert KJ, Margolis DJ. Predictors of malignancy development in patients with chronic pruritus. Journal of Dermatological Science. PMID 26874971 DOI: 10.1016/j.jdermsci.2016.01.010  0.72
2015 Olson E, Badder C, Sullivan S, Smith C, Propert KJ, Margulies SS. Alterations in Daytime and Nighttime Activity in Piglets after Focal and Diffuse Brain Injury. Journal of Neurotrauma. PMID 26414329 DOI: 10.1089/neu.2015.4085  0.72
2015 Jemielita T, Gerton GL, Neidell M, Chillrud S, Yan B, Stute M, Howarth M, Saberi P, Fausti N, Penning TM, Roy J, Propert KJ, Panettieri RA. Unconventional Gas and Oil Drilling Is Associated with Increased Hospital Utilization Rates. Plos One. 10: e0131093. PMID 26176544 DOI: 10.1371/journal.pone.0131093  0.72
2015 Andy UU, Arya LA, Smith AL, Propert KJ, Bogner HR, Colavita K, Harvie HS. Is self-reported adherence associated with clinical outcomes in women treated with anticholinergic medication for overactive bladder? Neurourology and Urodynamics. PMID 25995132 DOI: 10.1002/nau.22798  0.72
2015 Anyanwu CO, Fiorentino DF, Chung L, Dzuong C, Wang Y, Okawa J, Carr K, Propert KJ, Werth VP. Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change. The British Journal of Dermatology. PMID 25994337 DOI: 10.1111/bjd.13915  0.72
2015 Margulies SS, Kilbaugh T, Sullivan S, Smith C, Propert K, Byro M, Saliga K, Costine BA, Duhaime AC. Establishing a Clinically Relevant Large Animal Model Platform for TBI Therapy Development: Using Cyclosporin A as a Case Study. Brain Pathology (Zurich, Switzerland). 25: 289-303. PMID 25904045 DOI: 10.1111/bpa.12247  0.72
2015 Lindborg CM, Propert KJ, Pignolo RJ. Conservation of pro-longevity genes among mammals. Mechanisms of Ageing and Development. 146: 23-7. PMID 25804384 DOI: 10.1016/j.mad.2015.03.004  0.72
2015 Greer JA, Xu R, Propert KJ, Arya LA. Urinary incontinence and disability in community-dwelling women: a cross-sectional study. Neurourology and Urodynamics. 34: 539-43. PMID 24752925 DOI: 10.1002/nau.22615  0.72
2015 Andy UU, Harvie HS, Smith AL, Propert KJ, Bogner HR, Arya LA. Validation of a self-administered instrument to measure adherence to anticholinergic drugs in women with overactive bladder. Neurourology and Urodynamics. 34: 424-8. PMID 24719232 DOI: 10.1002/nau.22605  0.72
2014 Li X, Fries S, Li R, Lawson JA, Propert KJ, Diamond SL, Blair IA, FitzGerald GA, Grosser T. Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. Proceedings of the National Academy of Sciences of the United States of America. 111: 16830-5. PMID 25385584 DOI: 10.1073/pnas.1406997111  0.72
2014 Saberi P, Propert KJ, Powers M, Emmett E, Green-McKenzie J. Field survey of health perception and complaints of Pennsylvania residents in the Marcellus Shale region. International Journal of Environmental Research and Public Health. 11: 6517-27. PMID 25003172 DOI: 10.3390/ijerph110606517  0.72
2014 Habineza Ndikuyeze G, Gaurnier-Hausser A, Patel R, Baldwin AS, May MJ, Flood P, Krick E, Propert KJ, Mason NJ. A phase I clinical trial of systemically delivered NEMO binding domain peptide in dogs with spontaneous activated B-cell like diffuse large B-cell lymphoma. Plos One. 9: e95404. PMID 24798348 DOI: 10.1371/journal.pone.0095404  0.72
2014 Fett N, Haynes K, Propert KJ, Margolis DJ. Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practices. Journal of the American Academy of Dermatology. 70: 651-8. PMID 24485529 DOI: 10.1016/j.jaad.2013.11.045  0.72
2014 Wieczorek IT, Propert KJ, Okawa J, Werth VP. Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus. Jama Dermatology. 150: 291-6. PMID 24477339 DOI: 10.1001/jamadermatol.2013.9026  0.72
2014 Ferguson JF, Mulvey CK, Patel PN, Shah RY, Doveikis J, Zhang W, Tabita-Martinez J, Terembula K, Eiden M, Koulman A, Griffin JL, Mehta NN, Shah R, Propert KJ, Song WL, et al. Omega-3 PUFA supplementation and the response to evoked endotoxemia in healthy volunteers. Molecular Nutrition & Food Research. 58: 601-13. PMID 24190860 DOI: 10.1002/mnfr.201300368  0.72
2014 Verma SM, Okawa J, Propert KJ, Werth VP. The impact of skin damage due to cutaneous lupus on quality of life British Journal of Dermatology. 170: 315-321. PMID 24111880 DOI: 10.1111/bjd.12653  0.72
2014 Yang W, Propert KJ, Richard Landis J. Estimating the efficacy of an interstitial cystitis/painful bladder syndrome medication in a randomized trial with both non-adherence and loss to follow-up. Statistics in Medicine. 33: 3547-55. PMID 23225539 DOI: 10.1002/sim.5702  0.72
2013 Sullivan S, Friess SH, Ralston J, Smith C, Propert KJ, Rapp PE, Margulies SS. Improved behavior, motor, and cognition assessments in neonatal piglets. Journal of Neurotrauma. 30: 1770-9. PMID 23758416 DOI: 10.1089/neu.2013.2913  0.72
2013 DiNardo CD, Propert KJ, Loren AW, Paietta E, Sun Z, Levine RL, Straley KS, Yen K, Patel JP, Agresta S, Abdel-Wahab O, Perl AE, Litzow MR, Rowe JM, Lazarus HM, et al. Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia. Blood. 121: 4917-24. PMID 23641016 DOI: 10.1182/blood-2013-03-493197  0.72
2013 Ferguson JF, Patel PN, Shah RY, Mulvey CK, Gadi R, Nijjar PS, Usman HM, Mehta NN, Shah R, Master SR, Propert KJ, Reilly MP. Race and gender variation in response to evoked inflammation. Journal of Translational Medicine. 11: 63. PMID 23497455 DOI: 10.1186/1479-5876-11-63  0.72
2013 Sullivan S, Friess SH, Ralston J, Smith C, Propert KJ, Rapp PE, Margulies SS. Behavioral deficits and axonal injury persistence after rotational head injury are direction dependent. Journal of Neurotrauma. 30: 538-45. PMID 23216054 DOI: 10.1089/neu.2012.2594  0.72
2013 Cuchel M, Meagher EA, Theron HDT, Blom DJ, Marais AD, Hegele RA, Averna MR, Sirtori CR, Shah PK, Gaudet D, Stefanutti C, Vigna GB, Du Plessi AME, Propert KJ, Sasiela WJ, et al. Effi cacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: A single-arm, open-label, phase 3 study The Lancet. 381: 40-46. PMID 23122768 DOI: 10.1016/S0140-6736(12)61731-0  0.72
2013 Arya LA, Harvie HS, Andy UU, Cory L, Propert KJ, Whitmore K. Construct validity of an instrument to measure neuropathic pain in women with bladder pain syndrome. Neurourology and Urodynamics. 32: 424-7. PMID 22972593 DOI: 10.1002/nau.22314  0.72
2012 Lunardon L, Tsai KJ, Propert KJ, Fett N, Stanley JR, Werth VP, Tsai DE, Payne AS. Adjuvant rituximab therapy of pemphigus: a single-center experience with 31 patients. Archives of Dermatology. 148: 1031-6. PMID 22710375 DOI: 10.1001/archdermatol.2012.1522  0.72
2012 FitzGerald MP, Payne CK, Lukacz ES, Yang CC, Peters KM, Chai TC, Nickel JC, Hanno PM, Kreder KJ, Burks DA, Mayer R, Kotarinos R, Fortman C, Allen TM, Fraser L, ... ... Propert KJ, et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. The Journal of Urology. 187: 2113-8. PMID 22503015 DOI: 10.1016/j.juro.2012.01.123  0.72
2012 Zhang H, Qiao H, Frank RS, Huang B, Propert KJ, Margulies S, Ferrari VA, Epstein JA, Zhou R. Spin-labeling magnetic resonance imaging detects increased myocardial blood flow after endothelial cell transplantation in the infarcted heart. Circulation. Cardiovascular Imaging. 5: 210-7. PMID 22311739 DOI: 10.1161/CIRCIMAGING.111.966317  0.72
2012 Skarke C, Alamuddin N, Lawson JA, Cen L, Propert KJ, Fitzgerald GA. Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. Clinical Pharmacology and Therapeutics. 91: 986-93. PMID 22278334 DOI: 10.1038/clpt.2012.3  0.72
2012 Jain V, Abdulmalik O, Propert KJ, Wehrli FW. Investigating the magnetic susceptibility properties of fresh human blood for noninvasive oxygen saturation quantification. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 68: 863-7. PMID 22162033 DOI: 10.1002/mrm.23282  0.72
2011 Sekiguchi DR, Smith SB, Sutter JA, Goodman NG, Propert K, Louzoun Y, Rogers W, Luning Prak ET. Circulating lymphocyte subsets in normal adults are variable and can be clustered into subgroups. Cytometry. Part B, Clinical Cytometry. 80: 291-9. PMID 21472851 DOI: 10.1002/cyto.b.20594  0.72
2011 Dibble CT, Lima JA, Bluemke DA, Chirinos JA, Chahal H, Bristow MR, Kronmal RA, Barr RG, Ferrari VA, Propert KJ, Kawut SM. Regional left ventricular systolic function and the right ventricle: the multi-ethnic study of atherosclerosis right ventricle study. Chest. 140: 310-6. PMID 21330384 DOI: 10.1378/chest.10-1750  0.72
2011 Yang CC, Burks DA, Propert KJ, Mayer RD, Peters KM, Nickel JC, Payne CK, FitzGerald MP, Hanno PM, Chai TC, Kreder KJ, Lukacz ES, Foster HE, Cen L, Landis JR, et al. Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned. The Journal of Urology. 185: 901-6. PMID 21238993 DOI: 10.1016/j.juro.2010.10.053  0.72
2011 Sekiguchi DR, Sutter JA, Rickels MR, Naji A, Liu C, Propert KJ, Rogers WT, Prak ET. Analysis of B cell subsets following pancreatic islet cell transplantation in a patient with type 1 diabetes by cytometric fingerprinting. Journal of Immunological Methods. 363: 233-44. PMID 20933515 DOI: 10.1016/j.jim.2010.09.038  0.72
2010 Pontari MA, Krieger JN, Litwin MS, White PC, Anderson RU, McNaughton-Collins M, Nickel JC, Shoskes DA, Alexander RB, O'Leary M, Zeitlin S, Chuai S, Landis JR, Cen L, Propert KJ, et al. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Archives of Internal Medicine. 170: 1586-93. PMID 20876412 DOI: 10.1001/archinternmed.2010.319  0.72
2010 Cuker A, Arepally G, Crowther MA, Rice L, Datko F, Hook K, Propert KJ, Kuter DJ, Ortel TL, Konkle BA, Cines DB. The HIT Expert Probability (HEP) Score: A novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion Journal of Thrombosis and Haemostasis. 8: 2642-2650. PMID 20854372 DOI: 10.1111/j.1538-7836.2010.04059.x  0.72
2010 Foster HE, Hanno PM, Nickel JC, Payne CK, Mayer RD, Burks DA, Yang CC, Chai TC, Kreder KJ, Peters KM, Lukacz ES, FitzGerald MP, Cen L, Landis JR, Propert KJ, et al. Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. The Journal of Urology. 183: 1853-8. PMID 20303115 DOI: 10.1016/j.juro.2009.12.106  0.72
2008 Propert KJ, Mayer R, Nickel JC, Payne CK, Peters KM, Teal V, Burks D, Kusek JW, Nyberg LM, Foster HE. Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo. The Journal of Urology. 179: 552-5. PMID 18082224 DOI: 10.1016/j.juro.2007.09.035  0.72
2008 Shoskes DA, Berger R, Elmi A, Landis JR, Propert KJ, Zeitlin S. Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study. The Journal of Urology. 179: 556-60. PMID 18082223 DOI: 10.1016/j.juro.2007.09.088  0.72
2008 Nickel JC, Tripp DA, Chuai S, Litwin MS, McNaughton-Collins M, Landis JR, Alexander RB, Schaeffer AJ, O'Leary MP, Pontari MA, White P, Mullins C, Nyberg L, Kusek J. Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome. Bju International. 101: 59-64. PMID 17924985 DOI: 10.1111/j.1464-410X.2007.07196.x  0.72
2007 Keay S, Reeder JE, Koch K, Zhang CO, Grkovic D, Peters K, Zhang Y, Kusek JW, Nyberg LM, Payne CK, Propert KJ. Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG). World Journal of Urology. 25: 499-504. PMID 17694391 DOI: 10.1007/s00345-007-0205-4  0.72
2007 Propert KJ, Mayer R, Nickel JC, Payne CK, Peters KM, Teal V, Burks D, Kusek JW, Nyberg LM, Foster HE. Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin? The Journal of Urology. 178: 886-90. PMID 17631335 DOI: 10.1016/j.juro.2007.05.052  0.72
2007 Nickel JC, Tripp D, Teal V, Propert KJ, Burks D, Foster HE, Hanno P, Mayer R, Payne CK, Peters KM, Kusek JW, Nyberg LM. Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis. The Journal of Urology. 177: 1832-6. PMID 17437831 DOI: 10.1016/j.juro.2007.01.060  0.72
2007 Leiby BE, Landis JR, Propert KJ, Tomaszewski JE. Discovery of morphological subgroups that correlate with severity of symptoms in interstitial cystitis: a proposed biopsy classification system. The Journal of Urology. 177: 142-8. PMID 17162024 DOI: 10.1016/j.juro.2006.08.096  0.72
2007 Erickson DR, Propert KJ. Pregnancy and interstitial cystitis/painful bladder syndrome. The Urologic Clinics of North America. 34: 61-9. PMID 17145362 DOI: 10.1016/j.ucl.2006.10.006  0.72
2006 Nickel JC, Shoskes D, Wang Y, Alexander RB, Fowler JE, Zeitlin S, O'Leary MP, Pontari MA, Schaeffer AJ, Landis JR, Nyberg L, Kusek JW, Propert KJ. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? The Journal of Urology. 176: 119-24. PMID 16753385 DOI: 10.1016/S0022-5347(06)00498-8  0.72
2006 Propert KJ, Litwin MS, Wang Y, Alexander RB, Calhoun E, Nickel JC, O'Leary MP, Pontari M, McNaughton-Collins M. Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) Quality of Life Research. 15: 299-305. PMID 16468084 DOI: 10.1007/s11136-005-1317-1  0.72
2006 Nadler RB, Collins MM, Propert KJ, Mikolajczyk SD, Knauss JS, Landis JR, Fowler JE, Schaeffer AJ, Alexander RB. Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome. Urology. 67: 337-42. PMID 16442595 DOI: 10.1016/j.urology.2005.08.031  0.72
2006 Propert KJ, Mayer RD, Wang Y, Sant GR, Hanno PM, Peters KM, Kusek JW. Responsiveness of symptom scales for interstitial cystitis Urology. 67: 55-59. PMID 16413332 DOI: 10.1016/j.urology.2005.07.014  0.72
2006 Propert KJ, McNaughton-Collins M, Leiby BE, O'Leary MP, Kusek JW, Litwin MS. A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort study. The Journal of Urology. 175: 619-23; discussion 6. PMID 16407009 DOI: 10.1016/S0022-5347(05)00233-8  0.72
2005 Wu Y, Fedorov VV, Propert KJ. Optimal design for dose response using beta distributed responses. Journal of Biopharmaceutical Statistics. 15: 753-71. PMID 16078383 DOI: 10.1081/BIP-200067760  0.72
2005 Mayer R, Propert KJ, Peters KM, Payne CK, Zhang Y, Burks D, Culkin DJ, Diokno A, Hanno P, Landis JR, Madigan R, Messing EM, Nickel JC, Sant GR, Warren J, et al. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. The Journal of Urology. 173: 1186-91. PMID 15758738 DOI: 10.1097/01.ju.0000152337.82806.e8  0.72
2005 Israni AK, Feldman HI, Propert KJ, Leonard M, Mange KC. Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 5: 374-82. PMID 15643998 DOI: 10.1111/j.1600-6143.2004.00688.x  0.72
2005 Kersun LS, Propert KJ, Lautenbach E, Bunin N, Demichele A. Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis. Pediatric Blood & Cancer. 45: 162-9. PMID 15593235 DOI: 10.1002/pbc.20277  0.72
2004 Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP, Pontari MA, McNaughton-Collins M, Shoskes DA, Comiter CV, Datta NS, Fowler JE, Nadler RB, Zeitlin SI, Knauss JS, et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Annals of Internal Medicine. 141: 581-9. PMID 15492337 DOI: 10.7326/0003-4819-141-8-200410190-00005  0.72
2004 Alexander RB, Mann DL, Borkowski AA, Fernandez-Vina M, Klyushnenkova EN, Kodak J, Propert KJ, Kincaid M. Granulomatous prostatitis linked to HLA-DRB1*1501. The Journal of Urology. 171: 2326-9. PMID 15126814 DOI: 10.1097/01.ju.0000127759.10293.fa  0.72
2003 Nickel JC, Alexander RB, Schaeffer AJ, Landis JR, Knauss JS, Propert KJ. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. The Journal of Urology. 170: 818-22. PMID 12913707 DOI: 10.1097/01.ju.0000082252.49374.e9  0.72
2003 Sant GR, Propert KJ, Hanno PM, Burks D, Culkin D, Diokno AC, Hardy C, Landis JR, Mayer R, Madigan R, Messing EM, Peters K, Theoharides TC, Warren J, Wein AJ, et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. The Journal of Urology. 170: 810-5. PMID 12913705 DOI: 10.1097/01.ju.0000083020.06212.3d  0.72
2003 Leaf AN, Propert K, Corcoran C, Catalano PJ, Trump DL, Harris JE, Davis TE. Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882): An eastern cooperative oncology group study Medical Oncology. 20: 137-145. PMID 12835516 DOI: 10.1385/MO:20:2:137  0.72
2002 Propert KJ, Payne C, Kusek JW, Nyberg LM. Pitfalls in the design of clinical trials for interstitial cystitis. Urology. 60: 742-8. PMID 12429288 DOI: 10.1016/S0090-4295(02)01775-2  0.72
2002 Schaeffer AJ, Knauss JS, Landis JR, Propert KJ, Alexander RB, Litwin MS, Nickel JC, O'Leary MP, Nadler RB, Pontari MA, Shoskes DA, Zeitlin SI, Fowler JE, Mazurick CA, Kusek JW, et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. The Journal of Urology. 168: 1048-53. PMID 12187220 DOI: 10.1097/01.ju.0000024762.69326.df  0.72
2002 Schaeffer AJ, Landis JR, Knauss JS, Propert KJ, Alexander RB, Litwin MS, Nickel JC, O'Leary MP, Nadler RB, Pontari MA, Shoskes DA, Zeitlin SI, Fowler JE, Mazurick CA, Kishel L, et al. Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. The Journal of Urology. 168: 593-8. PMID 12131316  0.72
2002 Karlawish JHT, Casarett D, Propert KJ, James BD, Clark CM. Relationship between Alzheimer's disease severity and patient participation in decisions about their medical care Journal of Geriatric Psychiatry and Neurology. 15: 68-72. PMID 12083595  0.72
2002 Propert KJ, Alexander RB, Nickel JC, Kusek JW, Litwin MS, Landis JR, Nyberg LM, Schaeffer AJ. Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology. 59: 870-6. PMID 12031372 DOI: 10.1016/S0090-4295(02)01601-1  0.72
2002 Karlawish JHT, Casarett DA, James BD, Propert KJ, Asch DA. Do persons with dementia vote? Neurology. 58: 1100-1102. PMID 11940701  0.72
2002 Green RJ, Metlay JP, Propert K, Catalano PJ, Macdonald JS, Mayer RJ, Haller DG. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Annals of Internal Medicine. 136: 261-9. PMID 11848723  0.72
2002 Raper SE, Yudkoff M, Chirmule N, Gao GP, Nunes F, Haskal ZJ, Furth EE, Propert KJ, Robinson MB, Magosin S, Simoes H, Speicher L, Hughes J, Tazelaar J, Wivel NA, et al. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Human Gene Therapy. 13: 163-75. PMID 11779420 DOI: 10.1089/10430340152712719  0.72
2002 Schnell MA, Hardy C, Hawley M, Propert KJ, Wilson JM. Effect of blood collection technique in mice on clinical pathology parameters Human Gene Therapy. 13: 155-161. PMID 11779419 DOI: 10.1089/10430340152712700  0.72
2001 McNaughton Collins M, Pontari MA, O'Leary MP, Calhoun EA, Santanna J, Landis JR, Kusek JW, Litwin MS, Schaeffer AJ, Bennet CL, Bushman W, Duncan JL, Koch AE, Nadler RB, Rhodes D, ... ... Propert KJ, et al. Quality of life is impaired in men with chronic prostatitis: The chronic prostatitis collaborative research network Journal of General Internal Medicine. 16: 656-662. PMID 11679032 DOI: 10.1046/j.1525-1497.2001.01223.x  0.72
2001 Tada H, Maron DJ, Choi EA, Barsoum J, Lei H, Xie Q, Liu W, Ellis L, Moscioni AD, Tazelaar J, Fawell S, Qin X, Propert KJ, Davis A, Fraker DL, et al. Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases. The Journal of Clinical Investigation. 108: 83-95. PMID 11435460 DOI: 10.1172/JCI9841  0.72
2001 Lambright ES, Amin K, Wiewrodt R, Force SD, Lanuti M, Propert KJ, Litzky L, Kaiser LR, Albelda SM. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy Gene Therapy. 8: 946-953. PMID 11426335 DOI: 10.1038/sj.gt.3301489  0.72
2001 Bruce Malkowicz S, McKenna WG, Vaughn DJ, Wan XS, Propert KJ, Rockwell K, Marks SHF, Wein AJ, Kennedy AR. Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia Prostate. 48: 16-28. PMID 11391683 DOI: 10.1002/pros.1077  0.72
2001 Li YP, Propert KJ, Rosenbaum PR. Balanced Risk Set Matching Journal of the American Statistical Association. 96: 870-882.  0.72
2000 Rovner E, Propert KJ, Brensinger C, Wein AJ, Foy M, Kirkemo A, Landis JR, Kusek JW, Nyberg LM. Treatments used in women with interstitial cystitis: The Interstitial Cystitis Data Base (ICDB) study experience Urology. 56: 940-945. PMID 11113737 DOI: 10.1016/S0090-4295(00)00845-1  0.72
2000 Stettler N, Kawchak DA, Boyle LL, Propert KJ, Scanlin TF, Stallings VA, Zemel BS. Prospective evaluation of growth, nutritional status, and body composition in children with cystic fibrosis. The American Journal of Clinical Nutrition. 72: 407-13. PMID 10919935  0.72
2000 Stettler N, Kawachak DA, Boyle LL, Propert KJ, Scanlin TF, Stallings VA, Zemel BS. A prospective study of body composition changes in children with cystic fibrosis. Annals of the New York Academy of Sciences. 904: 406-9. PMID 10865779  0.72
2000 Propert KJ, Schaeffer AJ, Brensinger CM, Kusek JW, Nyberg LM, Landis JR. A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study Group. The Journal of Urology. 163: 1434-9. PMID 10751852  0.72
2000 Mazurick CA, Landis JR, Wein AJ, Foy M, Hanno PM, Monson F, Nigro D, Whitmore KE, Parsons CL, Stein P, Larison S, Williams M, LeBow D, Culkin DJ, Roy JB, ... ... Propert KJ, et al. Evaluation of repeat daily voiding measures in the national interstitial cystitis data base study Journal of Urology. 163: 1208-1211. PMID 10737498  0.72
1999 Zuckerman JB, Robinson CB, McCoy KS, Shell R, Sferra TJ, Chirmule N, Magosin SA, Propert KJ, Brown-Parr EC, Hughes JV, Tazelaar J, Baker C, Goldman MJ, Wilson JM. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Human Gene Therapy. 10: 2973-85. PMID 10609658 DOI: 10.1089/10430349950016384  0.72
1999 Chirmule N, Propert KJ, Magosin SA, Qian Y, Qian R, Wilson JM. Immune responses to adenovirus and adeno-associated virus in humans Gene Therapy. 6: 1574-1583. PMID 10490767 DOI: 10.1038/sj.gt.3300994  0.72
1999 Leonard MB, Propert KJ, Zemel BS, Stallings VA, Feldman HI. Discrepancies in pediatric bone mineral density reference data: Potential for misdiagnosis of osteopenia Journal of Pediatrics. 135: 182-188. PMID 10431112  0.72
1999 Litwin MS, McNaughton-Collins M, Fowler FJ, Nickel JC, Calhoun EA, Pontari MA, Alexander RB, Farrar JT, O'Leary MP, Landis JR, Schaeffer AJ, Barry MJ, Bennett CL, Bushman W, Ceri H, ... ... Propert KJ, et al. The National Institutes of Health chronic prostatitis symptom index: Development and validation of a new outcome measure Journal of Urology. 162: 369-375. PMID 10411041 DOI: 10.1016/S0022-5347(05)68562-X  0.72
1999 Clark JA, Rieker P, Propert KJ, Talcott JA. Changes in quality of life following treatment for early prostate cancer Urology. 53: 161-168. PMID 9886606 DOI: 10.1016/S0090-4295(98)00457-9  0.72
1998 Coleman M, Rafla S, Propert KJ, Glicksman A, Peterson B, Nissen N, Brunner K, Holland JF, Anderson JR, Gottlieb A, Kaufman T. Augmented therapy of extensive Hodgkin's disease: Radiation to known disease or prolongation of induction chemotherapy did not improve survival- results of a cancer and leukemia group B study International Journal of Radiation Oncology Biology Physics. 41: 639-645. PMID 9635714 DOI: 10.1016/S0360-3016(98)00071-6  0.72
1998 Beard CJ, Lamb C, Buswell L, Schneider L, Propert KJ, Gladstone D, D'Amico A, Kaplan I. Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer International Journal of Radiation Oncology Biology Physics. 41: 257-262. PMID 9607338 DOI: 10.1016/S0360-3016(98)00054-6  0.72
1998 Berlin JD, Propert KJ, Trump D, Wilding G, Hudes G, Glick J, Burch P, Keller A, Loehrer P. 5-Fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: an Eastern Cooperative Oncology Group phase II study (E1889). American Journal of Clinical Oncology. 21: 171-6. PMID 9537206 DOI: 10.1097/00000421-199804000-00016  0.72
1998 Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, Wishnow KI, Kaplan I, Loughlin KR, Richie JP, Kantoff PW. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 275-83. PMID 9440753  0.72
1997 Talcott JA, Rieker P, Propert KJ, Clark JA, Wishnow KI, Loughlin KR, Richie JP, Kantoff PW. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy Journal of the National Cancer Institute. 89: 1117-1123. PMID 9262249  0.72
1997 Saxman SB, Propert KJ, Einhorn LH, Crawford ED, Tannock I, Raghavan D, Loehrer PJ, Trump D. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study Journal of Clinical Oncology. 15: 2564-2569. PMID 9215826  0.72
1997 Dreicer R, Propert KJ, Kuzel T, Kirkwood JM, O'Dwyer PJ, Loehrer PJ. A Phase II trial of edatrexate in patients with advanced renal cell carcinoma: An Eastern Cooperative Oncology Group Study American Journal of Clinical Oncology: Cancer Clinical Trials. 20: 251-253. PMID 9167747 DOI: 10.1097/00000421-199706000-00008  0.72
1997 Beard CJ, Propert KJ, Rieker PP, Clark JA, Kaplan I, Kantoff PW, Talcott JA. Complications after treatment with external-beam irradiation in early- stage prostate cancer patients: A prospective multiinstitutional outcomes study Journal of Clinical Oncology. 15: 223-229. PMID 8996146  0.72
1997 Dreicer R, Propert KJ, Roth BJ, Einhorn LH, Loehrer PJ. Vinblastine, ifosfamide, and gallium nitrate - An active new regimen in patients with advanced carcinoma of the urothelium: A phase II trial of the eastern cooperative oncology group (E5892) Cancer. 79: 110-114. PMID 8988734 DOI: 10.1002/(SICI)1097-0142(19970101)79:1<110::AID-CNCR16>3.0.CO;2-7  0.72
1996 Mashal RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ, Dutta A. Expression of cell cycle-regulated proteins in prostate cancer Cancer Research. 56: 4159-4163. PMID 8797586  0.72
1996 D'Amico AV, Propert KJ. Prostate cancer volume adds significantly to prostate-specific antigen in the prediction of early biochemical failure after external beam radiation therapy International Journal of Radiation Oncology Biology Physics. 35: 273-279. PMID 8635933 DOI: 10.1016/0360-3016(95)02389-5  0.72
1993 Kreisman H, Lisbona A, Olson L, Propert KJ, Modeas C, Dillman RO, Seagren SL, Green MR. Effect of radiologic Stage III substage on nonsurgical therapy of non- small cell lung cancer Cancer. 72: 1588-1596. PMID 8394201  0.72
1993 Luikart SD, Goutsou M, Mitchell ED, Van Echo DA, Modeas CR, Propert KJ, O'Donnell J, Difino S, Perry MC, Green MR. Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer American Journal of Clinical Oncology: Cancer Clinical Trials. 16: 127-131. PMID 8383914 DOI: 10.1097/00000421-199304000-00009  0.72
1992 Hargis JB, Anderson JR, Propert KJ, Green MR, Van Echo DA. Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a cancer and leukemia group B study Cancer Chemotherapy and Pharmacology. 30: 291-296. PMID 1643697 DOI: 10.1007/BF00686298  0.72
1992 Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A, Peterson BA. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD New England Journal of Medicine. 327: 1478-1484. PMID 1383821  0.72
1992 Green MR, Kreisman H, Doll DC, Lyss AP, Clamon GH, Goutsou M, Perry MC, Propert KJ. Carboplatin in non-small cell lung cancer: An update on the Cancer and Leukemia Group B experience Seminars in Oncology. 19: 44-49. PMID 1329222  0.72
1991 Souhami RL, Spiro SG, Cullen M, Propert KJ, Dillman RO, Seagren SL, Green MR. Chemotherapy and radiation therapy as compared with radiation therapy in stage III non-small-cell cancer [3] New England Journal of Medicine. 324: 1136-1137. PMID 1848918  0.72
1991 Anderson JR, Crowley JJ, Propert KJ. Interpretation of survival data in clinical trials. Oncology (Williston Park, N.Y.). 5: 104-10; discussion 1. PMID 1826203  0.72
1990 Rybak ME, McCarroll K, Kaplan RJ, Propert KJ, Budman DR, Gottlieb AJ. Phase II trial of etoposide and cis-diaminodichloro-platinum in patients with refractory and relapsed Hodgkin's disease: Cancer and Leukemia Group B (CALGB) Study 8353. Medical and Pediatric Oncology. 18: 177-80. PMID 2329962 DOI: 10.1002/mpo.2950180302  0.72
1990 Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF, Green MR. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer New England Journal of Medicine. 323: 940-945. PMID 2169587  0.72
1990 Ringenberg QS, Propert KJ, Muss HB, Weiss RB, Schilsky RL, Modeas C, Perry MC, Norton L, Green M. Clinical cardiotoxicity of esorubicin (4′-deoxydoxorubicin,DxDx): Prospective studies with serial gated heart scans and reports of selected cases - A Cancer and Leukemia Group B report Investigational New Drugs. 8: 221-226. PMID 2166722 DOI: 10.1007/BF00177265  0.72
1990 Graziano SL, Lee K, Propert KJ, Tinsley R, Hayes DM, Green M, Comis RL. Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: a Cancer and Leukemia Group B Study. Medical and Pediatric Oncology. 18: 22-6. PMID 2152956 DOI: 10.1002/mpo.2950180105  0.72
1990 Chahinian AP, Propert KJ, Green MR. Warfarin anticoagulation for small-cell lung cancer: Evidence against a cytotoxic or anticoagulant mechanism: Reply Journal of Clinical Oncology. 8: 183-184.  0.72
1989 Chahinian AP, Propert KJ, Ware JH, Zimmer B, Perry MC, Hirsh V, Skarin A, Kopel S, Holland JF, Comis RL, Green MR. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B Journal of Clinical Oncology. 7: 993-1002. PMID 2547030  0.72
1988 Propert KJ, Anderson JR. Assessing the effect of toxicity on prognosis: Methods of analysis and interpretation Journal of Clinical Oncology. 6: 868-870. PMID 3367190  0.72
1988 Anderson JR, Propert KJ, Harrington DP. Guidelines for reporting outcomes of lymphoma trials Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 6: 559-560. PMID 3280745  0.72
1988 Ringenberg QS, Perry MC, Propert KJ, Modeas C, Hirsh V, Weiss RB, Richards F, Graziano S, Green M. Phase II trial of 4'-deoxydoxorubicin (DxDx) in non-small cell lung cancer: A cancer and leukemia group B trial Medical and Pediatric Oncology. 16: 27-29. PMID 2828901  0.72
1987 Luikart SD, Propert KJ, Modeas CR, Green MR, Perry MC. High-dose etoposide therapy for extensive small cell lung cancer: A cancer and leukemia group B study Cancer Treatment Reports. 71: 533-534. PMID 3032434  0.72
1987 Perry MC, Eaton WL, Propert KJ, Ware JH, Zimmer B, Chahinian AP, Skarin A, Carey RW, Kreisman H, Faulkner C. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung New England Journal of Medicine. 316: 912-918. PMID 3029592  0.72
1987 Kwiatkowski DJ, Propert KJ, Carey RW, Choi N, Green M. A phase II trial of cyclophosphamide, etoposide, and cisplatin with combined chest and brain radiotherapy in limited small-cell lung cancer: A Cancer and Leukemia Group B study Journal of Clinical Oncology. 5: 1874-1879. PMID 2824709  0.72
1987 Kreisman H, Ginsberg S, Propert KJ, Richards F, Graziano S, Green M. Carboplatin or iproplatin in advanced non-small cell lung cancer: A cancer and leukemia group B study Cancer Treatment Reports. 71: 1049-1052. PMID 2824045  0.72
1986 Propert KJ, Anderson JR, Barcos M, Gottlieb AJ. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 4: 1419-1420. PMID 3746379  0.72
1986 Green MR, Vosika G, Propert KJ, Ware JH, Comis R. Bisantrene in non-small cell lung cancer: A phase II trial of the cancer and leukemia group B Cancer Treatment Reports. 70: 539-540. PMID 3698052  0.72
1986 Cooper MR, McIntyre OR, Propert KJ, Kochwa S, Anderson K, Coleman M, Kyle RA, Prager D, Rafla S, Zimmer B. Single, sequential, and multiple alkylating agent therapy for multiple myeloma: A CALGB study Journal of Clinical Oncology. 4: 1331-1339. PMID 3528403  0.72
1986 Vinciguerra V, Propert KJ, Coleman M, Anderson JR, Stutzman L, Pajak TF, Nissen NI, Frizzera G, Gottlieb A, Holland JF. Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy: A prospectively randomized study by the cancer and leukemia group B Journal of Clinical Oncology. 4: 838-846. PMID 2423652  0.72
Show low-probability matches.